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While most cancers of the uterine cervix are squamous cell carcinomas, the relative and absolute incidence of adenocarcinoma of the
uterine cervix has risen in recent years. It is not clear to what extent risk factors identified for squamous cell carcinoma of the cervix
are shared by cervical adenocarcinomas. We used data from six case–control studies to compare directly risk factors for cervical
adenocarcinoma (910 cases) and squamous cell carcinoma (5649 cases) in a published data meta-analysis. The summary odds ratios
and tests for differences between these summaries for the two histological types were estimated using empirically weighted least
squares. A higher lifetime number of sexual partners, earlier age at first intercourse, higher parity and long duration of oral
contraceptive use were risk factors for both histological types. Current smoking was associated with a significantly increased risk of
squamous cell carcinoma, with a summary odds ratio of 1.47 (95% confidence interval: 1.15–1.88), but not of adenocarcinoma
(summary odds ratio¼0.82 (0.60–1.11); test for heterogeneity between squamous cell and adenocarcinoma for current smoking:
P¼0.001). The results of this meta-analysis of published data suggest that squamous cell and adenocarcinomas of the uterine cervix,
while sharing many risk factors, may differ in relation to smoking. Further evidence is needed to confirm this in view of the limited data
available.
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Most cancers of the uterine cervix are squamous cell carcinomas,
but the relative and absolute incidence of adenocarcinoma has
risen in recent years and adenocarcinomas now account for about
20% of incident invasive cervical cancers in screened populations
worldwide (Sasieni and Adams, 2001). It remains unclear to what
extent risk factors identified for squamous cell carcinoma of the
cervix are shared by cervical adenocarcinomas (Parazzini and La
Vecchia, 1990; Kjaer and Brinton, 1993; Altekruse et al, 2003;
Green et al, 2003). While infection with the human papillomavirus
(HPV) appears to be the most important cause of both types of
cervical cancer (Walboomers et al, 1999; Clifford et al, 2003), some
controlled studies have found differences between adenocarcinoma
and squamous cell carcinoma in the importance of other factors
such as smoking (Lacey et al, 2001; Green et al, 2003) and
reproductive factors (Altekruse et al, 2003). Individual studies
have generally been limited by small numbers of adenocarcinoma
cases and in some instances by lack of adjustment for confounding
factors. In the 10 years since this subject was last reviewed
(Parazzini and La Vecchia, 1990; Kjaer and Brinton, 1993), a
number of new studies have been published. In this meta-analysis
of published data, we have combined results from those controlled
studies that provided a direct comparison between risk factors for
squamous cell and adenocarcinoma, to assess the current evidence.
MATERIALS AND METHODS
Studies were identified through searches of MEDLINE (1966–June
2003, using combinations of the search terms ‘cervix neoplasms’,
‘risk factors’, ‘adenocarcinoma’ and ‘squamous cell carcinoma’)
and of bibliographies of identified papers. We included any
controlled study that provided the age-adjusted odds ratios and
95% confidence intervals (CIs) for both adenocarcinoma (includ-
ing adenosquamous carcinoma) and squamous cell carcinoma of
the cervix (invasive or in situ) for at least one of the following risk
factors (but not necessarily in the same publication): duration of
oral contraceptive use, smoking, reproductive factors and sexual
behaviour. Studies providing information on only one of the two
histological types were not included, to ensure that any potential
differences between the types were not due to study design or
setting. No limit was placed on the number of cases. The most
adjusted odds ratio available was used for analysis. In most
studies, oral contraceptive use was not further defined and may
include combined and progestagen-only oral contraceptives;
however, the large majority of oral contraceptive users in these
studies are likely to have used combined preparations (IARC,
1999).
Statistical methods
The odds ratios from each study were grouped into the closest of
the prespecified categories for each risk factor (e.g. for duration of
oral contraceptive use o5, 5–9 and 10þ years). To enable the
results for the studies that had been divided into more categories
to be included, it was necessary to combine some of the categories
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and Cox, 2003).
The summary (odds ratios, OR) for the pooled data were
calculated under a fixed effects model using the method of
empirically weighted least squares, where the weights are defined
as the inverse of the variance of the log odds ratios (Cox and Snell,
1989). Heterogeneity between individual study results and between
summary risk estimates for the two histological types was also
calculated using this method.
In Figure 1, summary OR for groups of studies are shown
as black circles whose size does not represent the amount of
data available. In Figure 2, OR for individual studies are plotted as
black squares whose size is inversely proportional to the variance
of the logarithm of the odds ratios diamonds represent
the summary odds ratios with 95% CIs indicated by their
horizontal extent.
RESULTS
Data were available from six case–control studies: by Brinton and
co-workers in the USA (Brinton et al, 1986) and Latin America
(Brinton et al, 1990, 1993); the World Health Organisation (WHO)
multicentre study (WHO, 1985; Thomas and Ray, 1996); a
multicentre study by Lacey and co-workers in the USA (Lacey
et al, 1999, 2001; Altekruse et al, 2003); a pooled analysis from the
International Agency for Research on Cancer (IARC) (Munoz et al,
2002; Plummer et al, 2003) of data from 10 individual studies, of
which two (Chichareon et al, 1998; Ngelangel et al, 1998) were
included individually in analyses for which the pooled IARC data
were not available; and the UK National Case–Control Study of
Cervical Cancer (Green et al, 2003). In total, data were available for
5649 cases of squamous cell carcinoma, 910 cases of adenocarci-
noma and 17384 controls. Details of the studies are given in
Table 1.
Figure 1 shows summary OR in relation to sexual behaviour,
reproductive factors, oral contraceptive use and smoking status,
based on data from between three and six studies. Both histological
types of cervical cancer showed a strong association with the
number of sexual partners, with cancer risk increasing with the
increasing number of partners. Summary OR (and 95% CIs) for
three or more lifetime partners compared with one partner were
1.94 (1.35–2.79) for adenocarcinoma and 2.44 (1.94–3.07) for
squamous cell carcinoma. There were no significant differences
between the results for adenocarcinoma and for squamous cell
carcinoma. Early age at first intercourse was associated with
increased risk of both types of cervical cancer, although the
association was stronger for squamous cell carcinoma (OR for age
at first intercourse of less than 17 years compared with more than
20 years 1.41 (0.99–2.00) for adenocarcinoma and 2.32 (1.89–2.85)
for squamous cell carcinoma; the difference between these ORs
was statistically significant (P¼0.009)).
Parity was strongly related to the risk of squamous cell
carcinoma (summary OR for three or more live births or full-
term pregnancies compared with none 2.71 (2.08–3.53)). It was
less strongly related to the risk of adenocarcinoma, although there
was still a statistically significant association (OR for parity of
three or more 1.51 (1.02–2.22)), and there appears to be a trend of
increasing risk with increasing parity for adenocarcinoma as for
squamous cell carcinoma. The difference between the OR for
adenocarcinoma and for squamous cell carcinoma in relation to
parity of three or more compared to none was statistically
Adenocarcinoma
Cases/controls  Variable No. studies
Lifetime number of partners (compared with one partner)                                   
~2−3 partners     4  253/−      1.58 (1.16−2.14)     1153/−    1.95 (1.62−2.34)    
~>3 partners     4  252/−     1.94 (1.35−2.79)     929/−      2.44 (1.94−3.07)    
Age at first intercourse (compared with 21+ years)        
~17−20 years     5  244/−       1.12 (0.79−1.57)     983/−     1.60 (1.33−1.92)    
~<17 years     5  254/−   1.41 (0.99−2.00)     1047/−      2.32 (1.89−2.85)    
Parity (compared with no births)       
1−2 births     3  242/1026    1.04 (0.76−1.41)     698/1026    1.38 (1.10−1.74)    
3+ births      3  255/708     1.51 (1.02−2.22)     1654/708    2.71 (2.08−3.53)    
Age at first birth (compared with 25+ years)                   
20-24 years     3  230/928     1.08 (0.80−1.46)     1055/928    1.02 (0.83−1.25)    
19 years     3  205/715     1.04 (0.73−1.48)     1322/715    1.27 (1.01−1.59)    
Duration of oral contraceptive use (compared with never use)                   
~<5 years      6  603/15353   1.33 (1.09−1.62)     3466/15353  1.11 (1.01−1.22)    
~5−9 years       6  483/11284   1.60 (1.19−2.15) 2836/11284  1.51  (1.29−1.77)    
~10+ years      4  371/10518   2.19 (1.58−3.02)     2438/10518  2.02 (1.72−2.37)    
Smoking status (compared with never smokers)        
Ever                                                                                                                                4  471/−      0.88 (0.69−1.11)     2870/− 1.23 (1.09−1.40)    
Past                                                                                                                                3  316/1047    0.88 (0.63−1.21)     1658/1047   0.93 (0.69−1.25)    
Current                                                                                                                             3  352/1213    0.82 (0.60−1.11)     1978/1213   1.47 (1.15−1.88)    
0.5 1.0 1.5 2.0 2.5 3.0 3.5 0.5 1.0 1.5 2.0 2.5 3.0 3.5
Test for heterogeneity between adeno and squamous cell carcinoma risks for: 
Partners: 2−3 partners P = 0.2; >3 partners P = 0.2; age at first intercourse: 17−20 years P = 0.04; <17 years P = 0.009
Parity: 1−2 births P = 0.08; 3+ births P = 0.006; age at first birth: 20−24 years P = 0.8; <20 years P = 0.4  
Oral contraceptive duration: <5 years P = 0.1; 5−10 years P = 0.7; 10+ years  P = 0.7
Smoking status: Ever P = 0.003; past P = 0.8; current P = 0.001
Cases/controls  
Squamous cell carcinoma
OR (95%CI) Odds ratio and 95%CI Odds ratio and 95%CI OR (95%CI) 
Figure 1 Summary ORs and 95% CIs for cervical cancer in relation to sexual behaviour, reproductive factors, oral contraceptive use and smoking status.
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either squamous cell or adenocarcinoma of the cervix.
Duration of use of oral contraceptives was strongly related to
risk for both adenocarcinoma and squamous cell carcinoma (OR
for 10 or more years use compared with never use, 2.19 (1.58–
3.02) and 2.02 (1.72–2.37), respectively), with no significant
difference between the results for the two cancer types.
Compared to never smokers, the risk of squamous cell
carcinoma was significantly increased in ever smokers (summary
OR¼1.23 (1.09–1.40) and in current smokers (summary
OR¼1.47 (1.15–1.88), although not in past smokers (summary
OR¼0.93 (0.69–1.25)). Adenocarcinoma risk was not associated
with smoking status (summary OR¼0.88 (0.69–1.11) for ever
smokers, 0.82 (0.60–1.11) for current smokers and 0.88 (0.63–
1.21) for past smokers compared to never smokers). There was a
statistically significant difference between the risks for squamous
cell and for adenocarcinoma for ever smoking (P¼0.003) and for
current smoking (P¼0.001).
Statistically significant heterogeneity between studies was
present in eight out of the 28 groups of studies (P-values for
significant heterogeneity between studies: squamous cell carcino-
ma, 43 partners P¼0.002, parity 1–2 P¼0.03, age at first birth
p19 years P¼o0.0001, o5 years oral contraceptive use P¼0.03,
past smoking P¼0.04; adenocarcinoma, parity 1–2 P¼o0.0001,
age at first birth p19years P¼0.03, o5 years oral contraceptive
use P¼0.04).
The individual study OR for ever, past and current smokers
compared to never smokers are shown in Figure 2. There was
statistical heterogeneity of marginal significance between indivi-
dual studies in one group only (squamous cell carcinoma in
relation to past smoking; P¼0.04).
Data on smoking intensity were available from two studies only:
the summary risk of squamous cell carcinoma increased with
increasing intensity of smoking (summary OR 1.22 (0.91–1.65)
and 1.39 (1.01–1.91) for less than 20 and 20 or more cigarettes per
day, respectively, compared to never smokers). The risk of
adenocarcinoma was not significantly increased for either group
of intensity of smoking compared to never smokers (summary OR
0.80 (0.56–1.13) and 0.77 (0.53–1.13) for less than 20 and 20 or
more cigarettes per day, respectively.) There was a statistically
significant difference between the results for squamous cell and for
adenocarcinoma for both levels of intensity (less than 20 cigarettes
per day, P¼0.04; 20 or more cigarettes per day, P¼0.01). No
heterogeneity between studies was present in any group. Only
three studies published results according to duration of smoking,
and of these only one (Green et al, 2003) published results for
duration of smoking restricted to current smokers. Because of the
difference in risk seen for squamous cell cervical cancer between
current and past smokers, it was not considered appropriate to
combine the results for duration of smoking.
DISCUSSION
The results of this meta-analysis show consistent qualitative
differences between the risks for squamous cell and adenocarci-
nomas of the cervix in relation to cigarette smoking. Smoking
appears to be a risk factor for squamous cell carcinoma, with an
increased risk of around 1.5 for current smokers, but not for
adenocarcinoma.
The other risk factors investigated did not differ qualitatively
between squamous cell and adenocarcinomas; both types of
cervical cancer were strongly related to the number of sexual
partners and to duration of oral contraceptive use, and both were
related to early age at first intercourse and to parity. Neither type
of cervical cancer was related to age at first birth in this analysis.
Adenocarcinoma Squamous cell carcinoma
Study Cases/controls
Exposed Unexposed
OR (95%CI) Odds ratio and 95%CI Cases/controls
Exposed Unexposed
OR (95%CI) Odds ratio and 95%CI
Ever smokers 
Brinton et al, 1993                                                                                                                     14/−      29/−    1.2 (0.6−2.4)         211/−   455/−   1.2 (0.9−1.4)       
Lacey et al,  2001                                                                                                                       62/144    62/163  0.8 (0.5−1.2)          92/144    47/163  1.4 (0.8−2.3)       
IARC, 2003                                                                                                                        18/36    106/218  1.64 (0.64−4.21)      409/36   1265/218  2.08 (1.33−3.27)    
UK National, 2003                                                                                                                108/529    72/394  0.80 (0.56−1.13)      270/529   121/394  1.05 (0.79−1.40)    
All studies                                                                                                                     0.88 (0.69−1.11)     1.23 (1.09−1.40)    
Test for heterogeneity between studies: P = 0.4 Test for heterogeneity between studies: P = 0.08
Past smokers 
Lacey et al,  2001                                                                                                                       40/77     62/163  1.0 (0.6−1.6)          31/77     47/163  1.1 (0.6−2.1)       
IARC, 2003                                                                                                                         4/14    106/218  1.15 (0.23−5.67)      134/14   1265/218  1.80 (0.95−3.44)    
UK National, 2003                                                                                                                 32/181    72/394  0.75 (0.46−1.20)       60/181   121/394  0.70 (0.47−1.03)    
All studies                                                                                                                     0.88 (0.63−1.21)     0.93 (0.69−1.25)    
Test for heterogeneity between studies: P = 0.7 Test for heterogeneity between studies: P = 0.04
Current smokers
Lacey et al,  2001                                                                                                                       22/68     62/163  0.6 (0.3−1.1)          60/68     47/163  1.6 (0.9−2.9)       
IARC, 2003                                                                                                                        14/22    106/218  1.90 (0.64−5.65)      275/22   1265/218  2.30 (1.31−4.04)    
UK National, 2003                                                                                                                 76/348    72/394  0.82 (0.56−1.21)      210/348   121/394  1.26 (0.93−1.71)    
All studies                                                                                                                     0.82 (0.60−1.11)     1.47 (1.15−1.88)    
Test for heterogeneity between studies: P = 0.2 Test for heterogeneity between studies: P = 0.7
0.0 1.0 2.0 3.0 4.0 0.0 1.0 2.0 3.0 4.0
Figure 2 Odds ratios and 95%CIs for cervical cancer for ever, past and current smokers vs never smokers.
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probably a necessary, causal factor for both squamous cell and
adenocarcinoma of the cervix, these findings confirm the
impression from recent individual studies that the two main
histological types of cervical cancer share the majority of risk
factors. The risk factors for cervical adenocarcinoma differ
substantially from those for endometrial adenocarcinoma; high
parity and the use of oral contraceptives decrease the risk of
endometrial cancer, and there is no evidence for an association
between endometrial cancer and sexual behaviour or HPV
infection (Altekruse et al, 2003; Green et al, 2003; Kjaer and
Brinton, 1993).
This meta-analysis of published observational data has a
number of limitations (Egger et al, 1998). The most serious is
the difference between studies in adjustment for possible
confounding factors and for HPV exposure or infection (see
Table 1). The four studies included in the smoking meta-analysis,
however, all gave results restricted to HPV-positive women
(Plummer et al, 2003) or adjusted for HPV status (Lacey et al,
2001) or for lifetime number of sexual partners, a reasonable
surrogate for HPV exposure (Brinton et al, 1993; Green et al,
2003). Two studies did not provide results adjusted for HPV
infection or exposure (WHO, 1985; Brinton et al, 1986; Thomas
and Ray, 1996); both were included only in the meta-analysis of
oral contraceptive use, and the results of this analysis were not
materially altered when these two studies were omitted. Differ-
ences in the risk factor categories used, for example for duration of
oral contraceptive use, may also contribute to the statistical
heterogeneity seen between studies in some groups. Overall, the
number of studies that have published results in a similar way for
both squamous cell and adenocarcinoma of the cervix is small, and
for some of the analyses the number of studies was very limited.
This meant that it was not feasible to investigate heterogeneity
between studies formally with respect to different study character-
istics. For all of these reasons, the magnitude of the summary odds
ratios should be interpreted cautiously.
Observed differences between the risks for squamous cell and
for adenocarcinomas could be due to selection or reporting biases,
or to differential residual confounding with other risk factors.
Cervical screening, for example, is thought to be more effective in
detecting squamous cell than adenocarcinomas (Mitchell et al,
1995; Bergstrom et al, 1999); while all studies in this meta-analysis
provided results adjusted for screening, the extent of adjustment
was variable. However, factors such as these seem unlikely to
explain the differences observed in relation to smoking as the two
histological types did not differ substantially in the analyses for
sexual behaviour, oral contraceptive use or reproductive factors.
Some of these factors, such as oral contraceptive use, are known to
be related to cervical screening (Eaker et al, 2001). The similarities
with respect to other risk factors also suggest that there is unlikely
to have been substantial misclassification of cervical adenocarci-
nomas in these studies (Green et al, 2003).
Some other epithelial cancers, for example those of the nasal
cavity, the oesophagus and possibly the lung, appear to show
differences between squamous cell and adenocarcinomas in
relation to smoking, with the effect of smoking being greater for
squamous cell tumours (IARC, 2004, in press). The results of this
meta-analysis of available published data suggest that smoking
increases the risk of squamous cell carcinoma of the cervix, but has
no clear effect on the risk of adenocarcinoma of the cervix. Further
studies are needed to confirm this finding.
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